Biotech

All Articles

Amgen files 1st period 3 win for $400M dermatitis drug

.Amgen has actually shared (PDF) the initial phase 3 information on its $400 million eczema medicine...

Biogen, UCB document phase 3 lupus succeed after failing earlier trial

.Biogen and UCB's bet one's bottom dollar developing in to stage 3 astride an unsuccessful study wan...

Aptadir hopes brand-new RNA preventions may reverse challenging cancers cells

.Italian biotech Aptadir Rehabs has actually launched along with the promise that its pipe of precli...

Wave surfs DMD results to regulatory authorities' doors, sending out stockpile

.Surge Lifestyle Sciences has actually satisfied its objective in a Duchenne muscle dystrophy (DMD) ...

Sanofi picks brand-new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is actually coming back to the pharma fold, usin...

Achilles droplets tissue therapy program, bandages for unemployments after skipping 'office practicality' objectives

.Achilles Therapies has wrecked its own method. The British biotech is quiting working on its clinic...

Aligos proclaims phase 2 MASH succeed, reducing liver body fat up to 46%

.Aligos Therapeutics is actually proclaiming a midstage gain in metabolic-dysfunction associated ste...

Basilea credit ratings $268M BARDA financing for antifungals, antibiotics

.Basilea Pharmaceutica's job building brand new antifungals has gotten a substantial increase from t...

Capricor offers Europe civil liberties to late-stage DMD treatment for $35M

.Possessing already gathered up the U.S. civil rights to Capricor Therapeutics' late-stage Duchenne ...

FDA junks adcomm for Applied's uncommon ailment medication

.After dismissing the choice date for Applied Rehabs' metabolic ailment drug govorestat, the FDA has...